| 9. |
ACCRUED EXPENSES AND LONG-TERM LIABILITIES |
Other accrued expenses consisted of the
following as of March 31, 2021 and December 31, 2020:
| |
|
March 31, 2021 |
|
|
December 31, 2020 |
|
| |
|
(unaudited) |
|
|
|
|
| Accrued royalties |
|
$ |
2,984 |
|
|
$ |
2,710 |
|
| Contingent consideration |
|
|
437 |
|
|
|
398 |
|
| Upfront Medicare payment |
|
|
2,066 |
|
|
|
2,066 |
|
| Operating lease liability |
|
|
894 |
|
|
|
1,027 |
|
| Financing lease liability |
|
|
150 |
|
|
|
177 |
|
| Deferred revenue |
|
|
52 |
|
|
|
54 |
|
| Accrued sales and marketing - diagnostics |
|
|
75 |
|
|
|
51 |
|
| Accrued lab costs - diagnostics |
|
|
160 |
|
|
|
161 |
|
| Accrued professional fees |
|
|
538 |
|
|
|
854 |
|
| Taxes payable |
|
|
331 |
|
|
|
334 |
|
| Unclaimed property |
|
|
565 |
|
|
|
565 |
|
| All others |
|
|
1,170 |
|
|
|
1,398 |
|
| Total other accrued expenses |
|
$ |
9,422 |
|
|
$ |
9,795 |
|
Long-term liabilities consisted of the following
as of March 31, 2021 and December 31, 2020:
| |
|
March 31, 2021 |
|
|
December 31, 2020 |
|
| |
|
(unaudited) |
|
|
|
|
| Warrant liability |
|
$ |
62 |
|
|
$ |
21 |
|
| Uncertain tax positions |
|
|
4,396 |
|
|
|
4,342 |
|
| Deferred revenue |
|
|
123 |
|
|
|
136 |
|
| Other |
|
|
111 |
|
|
|
138 |
|
| Total other long-term liabilities |
|
$ |
4,692 |
|
|
$ |
4,637 |
|
|